1Vanhanen M, Koivisto K, Moilanen I., et al. Association of metabolic syndrome with Alzheimer disease:a population-based study[J]. Neurology, 2006,67 : 843.
2Martins IJ, Hone E, Foster JK,et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease[J]. Mol Psychiatry, 2006.11 : 721.
3Lester Coil N, Rivera EJ, Soscia SJ, et al. Intracerebral streptozotocin model of type 3 diabetes:relevance to sporadic Alzheimer's disease[J]. J Alzheimers Dis, 2006,9 : 13.
4Sun MK, Alkon DL. I.inks between Alzheimer's disease and diabetes[J]. Drugs Today( Barc), 2006,42 : 481.
5Steen E,Terry BM,Rivera EJ,et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's diseaseis this type 3 diabetes[J]. J Alzheimers Dis, 2005,7 : 63.
6Hoyer S,I.ee SK,I.offler T,et al. Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzhei mer disease[J]. Ann N Y Acad Sci,2000,920:256.
7Frolich L,Blum-Degen D,Riederer P, et al. A disturbance in the neuronal insulin receptor signal transduction in spo radic Alzheimer's disease[J]. Ann N Y Acad Sci, 1999, 893:290.
8Frolich L, Hoyer S. Etiologic and pathogenetic heteroge neity of Alzheimer disease[J]. Nervenarzt, 2002,73 : 422.
9Liolitsa D, Powell J, Lovestone S. Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry, 2002,73 : 261.
10Berrino F. Western diet and Alzheimer's disease[J]. Epi demiol Prev, 2002,26 : 107.
3Mann KM, Thorngate FE, Katoh-Fukui Y, et al. Independent effects of ApoE on cholesterol metabolism and brain Ab levels in:an Alzheimer disease mouse model[J]. Hum Mol Genet,2004,13(17) : 1959.
4Laferla FM, Oddo S. Alzheimer disease : Abeta, tau and synaptic dysfounction[J]. Trends Mol Med,2005,11: 170.
6Schneider A, Schulz-Schaeffer W, Hartmann T, et al. Cholesterol depletion reduces aggregation of amyloid beta peptide in hippocampal neurons[J]. Neurobiol Dis,2006, 23(3) :573.
7Ghnbi O,Larsen B,Schrag M,et al. High cholesterol con tent in neurons increases BACE, beta-amyloid, and phos phoryhted tau levels in rabbit hippocampus[J].Exp Neu rol, 2006,200(2) :460.
8Ehehalt R, Keller P, Haass C, et al. Amyloidogenic pro cessing of the Alzheimer β-amyloid precursor protein de pends on lipid rafts[J].J Cell Biol, 2003,160 ( 1 ):113.
9Huttunen HJ, Greco C, Kovaes DM. Knockdown of ACAT 1 reduces amyloidogenic processing of APP[J]. FEBS Lett,2007,581(8): 1688.
10Hutter-Paier B, Huttunen H J, Puglielli L, et al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease[J]. Neuron, 2004,44 (2) : 227.
